:: ::
برگشت به فهرست مقالات برگشت به فهرست نسخه ها
اثر تمرین مقاومتی- هوازی ترکیبی بر میزان NT- proBNP، فشار خون و ترکیب بدن بیماران مبتلا به نارسایی مزمن قلب
زهرا محمودی ، رامین شعبانی* ، زهرا حجتی ذی دشتی ، محبوبه قلی پور
گروه تربیت بدنی و علوم ورزشی، دانشکده علوم انسانی، دانشگاه آزاد اسلامی واحد رشت، ایران ، shabani_msn@yahoo.com
چکیده:   (196 مشاهده)
سابقه و هدف: نارسایی قلب با تغییرات ساختاری و عملکردی قلب همراه بوده و فعالیت بدنی یک مداخله احتمالی برای بهبود آن است. هدف از مطالعه حاضر، بررسی اثر یک دوره تمرین مقاومتی- هوازی ترکیبی بر میزان NT- proBNP، فشار­­خون و ترکیب بدن بیماران مبتلا به نارسایی مزمن قلب می ­باشد.
مواد و روش ­ها: در این مطالعه کار­آزمایی بالینی، تعداد 76 بیمار نارسایی مزمن قلب، درجه II و III طبقه ­بندی انجمن قلب نیویورک و کسر جهشی 40 درصد با دامنه سنی (7±72 سال)، به­ طور یکسان و تصادفی به دو گروه مداخله و شاهد تقسیم شدند. برنامه گروه مداخله، شامل تمرینات هوازی (85-50 درصد ضربان قلب بیشینه) و مقاومتی (70-50 درصد یک تکرار بیشینه) به­ مدت 8 هفته، سه جلسه در هفته با تعیین درک شدت تمرین، مقیاس 10 امتیازی بورگ انجام شد. متغیر­­های سطح پلاسمایی NT-pro BNP، فشارخون و ترکیب بدن، قبل و 8 هفته بعد از تمرینات اندازه­ گیری شدند.
نتایج: 8 هفته تمرینات ترکیبی، باعث کاهش معنی­ دار در وزن، شاخص توده بدن، نسبت دور کمر به لگن، ضربان قلب و NT-proBNP در گروه مداخله شد (0/05<Pاما در مقایسه بین‌گروهی در پس‌آزمون، تفاوت در WHR و BMI معنی­ دار نبود. همچنین تغییرات بین و درون­ گروهی متغیرهای فشارخون سیستول، دیاستول و میانگین فشار شریانی مشاهده نشد.
نتیجه­ گیری: به ­نظر می­ رسد، تمرینات ترکیبی بر کاهش وزن و میزان NT- proBNP مؤثر است. بنابراین، برنامه تمرینی حاضر می ­تواند به ­عنوان مداخلات غیردارویی در بیماران مبتلا به نارسایی قلبی پیشنهاد شود.
واژه‌های کلیدی: تمرینات ترکیبی، نارسایی احتقانی قلبی، NT-pro BNP، ترکیب بدن، فشارخون
     
نوع مطالعه: پژوهشي | موضوع مقاله: medicine, paraclinic
دریافت: ۱۳۹۷/۹/۲۶ | پذیرش: ۱۳۹۸/۲/۴
فهرست منابع
1. Savarese G, Lund LH. Global public health burden of heart failure. Cardiac Fail Rev 2017; 3(1): 7–11.
2. Piepoli MF, Conraads V, CorrÁ U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: From theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 2011; 13(4): 347–57.
3. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: A review. Kidney Int 2011; 80: 806–21.
4. Stanek B, Frey B, Hülsmann M, Berger R, Sturm B, Strametz-Juranek J, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38(2): 436–42.
5. Felker GM, Whellan D, Kraus WE, Clare R, Zannad F, Donahue M, et al. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. Am Heart J 2009; 158(4): 37-44.
6. Raizada A, Bhandari S, Khan MA, Singh HV, Thomas S, Sarabhai V, et al. Brain type natriuretic peptide (BNP) -a marker of new millennium in diagnosis of congestive heart failure. Indian J Clin Biochem 2007; 22(1): 4-9.
7. Gaggin HK, Mohammed AA, Bhardwaj A, Rehman SU, Gregory SA, Weiner RB, et al. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: Results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. J Cardic Failure 2012; 18(8): 626–34.
8. Kubanek M, Goode KM, Lanska V, Clark AL, Cleland JG.‌ The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Failure 2009; 11(4): 367–77.
9. Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375(9718):895–905.
10. Nakatsu T, Shinohata R, Mashima K, Yuki Y, Nishitani A, Toyonaga S, et al. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers. Hypertens Res 2007; 30(7): 651–8.
11. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, et al. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25(20): 1797–805.
12. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol 2014; 176(3): 611–7.
13. Jewiss D, Ostman C, Smart NA. The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis. Int J Cardiol 2016; 221:674–81.
14. Passino C, Severino S, Poletti R, Piepoli MF, Mammini C, Clerico A, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 2006; 47(9): 1835–9.
15. Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D’Agostino M, et al. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: Favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Eur J Cardiovasc Prev Rehabil 2008; 15(1):113–8.
16. Pareja-Galeano H, Garatachea N, Lucia A. Exercise as a Polypill for Chronic Diseases. Prog Mol Biol Transl Sci 2015; 135: 497-526.
17. Smart NA, Meyer T, Butterfield JA, Faddy SC, Passino C, Malfatto G, et al. Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure. Eur J Prev Cardiol 2012; 19(3): 428–35.
18. Giallauria F, Lorenzo AD, Pilerci F, Manakos A, Lucci R, Psaroudaki M, et al. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction. Eur J Cardiovasc Prev Rehabil 2006; 13(4):625-632.
19. Erbs S, Höllriegel R, Linke A, Beck EB, Adams V, Gielen S, et al. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail 2010; 3(4): 486-94.
20. Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, Shu Y, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107(25): 3152-8.
21. Cittadini A, Monti MG, Iaccarino G, Castiello MC, Baldi A, Bossone E, et al. SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovasc Res 2012; 96(3): 381-90.
22. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA, American College of Sports Medicine American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36(3): 533–53.
23. Myers J. Cardiology patient pages. Exercise and cardiovascular health. Circulation 2003; 107: e2–e5.
24. Ahmad T, Fiuzat M, Mark DB, Neely B, Neely M, Kraus WE, et al. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. Am Heart J 2014; 167(2): 193-202. e1.
25. Nilsson BB, Westheim A, Risberg MA, Arnesen H, Seljeflot I. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure. Scandinavian Cardiovascular J 2010; 44(4): 223-9.
26. Ferguson S, Gledhill N, Jamnik VK, Wiebe C, Payne N. Cardiac performance in endurance-trained and moderately active young women. Med Sci Sports Exerc 2001; 33(7): 1114–9.
27. Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005; 307(5708):418–20.
28. Maiorana A, O'Driscoll G, Cheetham C, Collis J, Goodman C, Rankin S, et al. Combined aerobic and resistance exercise training improves functional capacity and strenght in CHF. J Appl Physiol 2000; 88(5): 1565-70.
29. Maiorana A, O'Driscoll G, Dembo L, Cheetham C, Goodman C, Taylor R, et al. Effect of aerobic and resistance exercise training on vascular function in heart failure. Am J Physiology-Heart Circulatory Physiol 2000; 279(4): H1999-H2005.
30. Taylor RS, Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal H, et al. Exercise‐based rehabilitation for heart failure. Cochrane Database Systematic Reviews 2014(4).
31. Pearson MJ, Smart NA. Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev 2018; 23(1):91-108.
32. Gary RA, Cress ME, Higgins MK, Smith AL, Dunbar SB. A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study. J Cardiovas Nurs 2012; 27(5):418.
33. Dean A, Sciences H, Kingston RI, Island R, Edith PC, Heart BF, et al. ACSM”S Guidelines for Exercise Testing and Prescription. 10th ed. Philadelphia: American College of Sports Medicine, Wolters Kluwer Health; 2018. p. 249.
34. Sturm B, Quittan M, Wiesinger GF, Stanek B, Frey B, Pacher R. Moderate-intensity exercise training with elements of step aerobics in patients with severe chronic heart failure. Arch Phys Med Rehabil 1999; 80(7): 746–50.
35. Godsen R, Carroll T, Stone S. How well does the Polar Vantage XL heart rate monitor estimate actual heart rate? Med Sci Sports Exerc 1991; 23(4):14.
36. Leger L, Thivierge M. Heart rate monitors: validity, stability and functionality. Phys Sports Med 1988; 16(5):143–51.
37. Borg G. Borg’s Perceived Exertion and Pain Scales. Champaign, IL: Human Kinetics; 1998.
38. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14(5): 377–81.
39. Giuliano C, Karahalios A, Neil C, Allen J, Levinger I. The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure—A meta-analysis. Int J Cardiol 2017; 227: 413–23.
40. Rengo G, Parisi V, Femminella GD, Pagano G, de Lucia C, Cannavo A, et al. Molecular aspects of the cardio protective effect of exercise in the elderly. Aging Clin Experimental Res 2013; 25(5): 487-97.
41. Gastelurrutia P, Nescolarde L, Rosell Ferrer J, et al. Bioelectrical impedance vector analysis (BIVA) in stable and nonstable heart failure patients: a pilot study. Int J Cardiol 2011; 146(2): 262-4.
42. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure. Circulation 1999; 99(9): 1173-82.
43. Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Circulation 1995; 91(11): 2775-84.
44. Giannuzzi P, Temporelli PL, Corrà U, Tavazzi L. Antiremodeling Effect of Long-Term Exercise Training in Patients With Stable Chronic Heart Failure. Circulation 2003; 108(5): 554-9.
45. Volaklis KA, Tokmakidis SP. Resistance Exercise Training in Patients with Heart Failure. Sports Med 2005; 35(12): 1085-103.
46. Franklin BA, Bonzheim K, Gordon S, Timmis GC. Resistance training in cardiac rehabilitation. J Cardiopulm Rehabil 1991; 11(2): 99-107
47. Rehabilitation M. Resistance Training for Cardiac Patients. Hypertension 2008; 12(6): 22–8.
48. Caminiti G, Volterrani M, Marazzi G, Cerrito A, Massaro R, Arisi A, et al. Tai Chi Enhances the Effects of Endurance Training in the Rehabilitation of Elderly Patients with Chronic Heart Failure. Rehabili Res Practice 2011; 2011: 1-6.
50. Lu WA, Kuo CD. The effect of Tai Chi Chuan on the autonomic nervous modulation in older persons. Med Sci Sports Exerc 2003; 35(12): 1972–6.


XML   English Abstract   Print



برگشت به فهرست مقالات برگشت به فهرست نسخه ها